insider trading  viking global opportunities illiquid investments submaster lp  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  viking global opportunities illiquid investments submaster lp select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in common stock purchase or sale transactiondate reporteddate company symbol insiderrelationship sharestraded averageprice totalamount sharesowned filing purchasea  pm editas medicine inc edit viking global investors lpviking global opportunities illiquid investments submaster lpviking global opportunities portfolio gp llcviking global opportunities gp llchalvorsen ole andreasott david csundheim daniel sother    9indirectdirect view purchase 9 pm editas medicine inc edit viking global investors lpviking global opportunities illiquid investments submaster lpviking global opportunities portfolio gp llcviking global opportunities gp llchalvorsen ole andreasott david csundheim daniel s owner    9indirectdirect view a indicate amendment filing stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing conversion  pm nana editas medicine inc edit viking global investors lpviking global opportunities illiquid investments submaster lpviking global opportunities portfolio gp llcviking global opportunities gp llchalvorsen ole andreasott david csundheim daniel sother 9  9indirect view conversion  pm nana editas medicine inc edit viking global investors lpviking global opportunities illiquid investments submaster lpviking global opportunities portfolio gp llcviking global opportunities gp llchalvorsen ole andreasott david csundheim daniel sother 9  9direct view conversion  pm nana editas medicine inc edit viking global investors lpviking global opportunities illiquid investments submaster lpviking global opportunities portfolio gp llcviking global opportunities gp llchalvorsen ole andreasott david csundheim daniel sother   9indirect view conversion  pm nana editas medicine inc edit viking global investors lpviking global opportunities illiquid investments submaster lpviking global opportunities portfolio gp llcviking global opportunities gp llchalvorsen ole andreasott david csundheim daniel sother   9direct view conversion 9 pm nana editas medicine inc edit viking global investors lpviking global opportunities illiquid investments submaster lpviking global opportunities portfolio gp llcviking global opportunities gp llchalvorsen ole andreasott david csundheim daniel s owner 9  9indirect view conversion 9 pm nana editas medicine inc edit viking global investors lpviking global opportunities illiquid investments submaster lpviking global opportunities portfolio gp llcviking global opportunities gp llchalvorsen ole andreasott david csundheim daniel s owner 9  9direct view conversion 9 pm nana editas medicine inc edit viking global investors lpviking global opportunities illiquid investments submaster lpviking global opportunities portfolio gp llcviking global opportunities gp llchalvorsen ole andreasott david csundheim daniel s owner   9indirect view conversion 9 pm nana editas medicine inc edit viking global investors lpviking global opportunities illiquid investments submaster lpviking global opportunities portfolio gp llcviking global opportunities gp llchalvorsen ole andreasott david csundheim daniel s owner   9direct view   secformcom all rights reserved archives        fri  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  d filing viking global and arbutus biopharma corp abus  insider monkey companies  see all hedge funds  see all insiders  see all institutional investors  see all click here to see all results for sorry no results has been found matching your query adblocker detected dear valued visitor we have noticed that you are using an ad blocker software although advertisements on the web pages may degrade your experience our business certainly depends on them and we can only keep providing you highquality research based articles as long as we can display ads on our pages to view this article you can disable your ad blocker and refresh this page or simply login we only allow registered users to use ad blockers you can sign up for free by clicking here or you can login if you are already a member hedge funds d filing viking global and arbutus biopharma corp abus published on july   at  pm by insider monkey staff in hedge funds page  of next gtgt you can access the original sec filing by clicking here ownership summary table name sole voting power shared voting power sole dispositive power shared dispositive power aggregate amount owned power percent of class viking global investors      9 viking global performance      9 viking global equities      9 viking global equities ii      9 vge iii portfolio ltd      9 viking long fund gp      9 viking long fund master ltd      9 viking global opportunities gp      9 viking global opportunities portfolio gp      9 viking global opportunities illiquid investments submaster      9 o andreas halvorsen      9 david c ott      9 rose s shabet      9 andreas halvorsenviking global page  of  – sec filing securities and exchange commissionwashington dc  schedule drule d information to be included in statements filed pursuant to § da and amendments thereto filed pursuant to da under the securities exchange act of 9 amendment no  arbutus biopharma corporation name of issuer common shares no par value title of class of securities 9j cusip number eric komitee general counsel  railroad avenue greenwich connecticut   name address and telephone number of person authorized to receive notices and communications july   date of event which requires filing of this statement if the filing person has previously filed a statement on schedule g to report the acquisition that is the subject of this schedule d and is filing this schedule because of §§de df or dg check the following box ☐ note schedules filed in paper format shall include a signed original and five copies of the schedule including all exhibits see §d for other parties to whom copies are to be sent continued on following pages page  of  pages   the remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page the information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of section  of the securities exchange act of 9 “act” or otherwise subject to the liabilities of that section of the act but shall be subject to all other provisions of the act however see the notes follow arbutus biopharma corp nasdaqabusfollow arbutus biopharma corp nasdaqabus trade nasdaqabus now page  of next gtgt related insider monkey articlesd filing abdiel qualified master fund lp and appian corp appnd filing mhr fund management and emisphere technologies inc emisd filing jana partners and eqt corporation eqtd filing cable car capital llc and insignia systems inc isigd filing healthcor management lp and careview communications inc crvwd filing aldebaran capital llc and rubicon technology inc rbcn arbutus biopharma corp abus hedge fund nasdaqabus sec d filing viking global insider monkey small cap strategy download a free copy of our newsletter and see the details inside hedge fund resource center how to beat the market by  percentage points why track hedge funds download a free edition why you should dump your hedge funds  things you didnt know about hedge funds billionaire hedge funds warren buffett berkshire hathaway 9 david einhorn greenlight capital  george soros soros fund management  t boone pickens bp capital  jim simons renaissance technologies  leon cooperman omega advisors 9 carl icahn icahn capital lp  steve cohen point asset management  john paulson paulson  co 9 david tepper appaloosa management lp  about us contact us terms of use privacy policy next post home hedge funds markets blog authors about us contact us privacy policy terms of use site map all text and design is copyright  koala guide llc all rights reserved viking global opportunities illiquid investments submaster lp  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors viking global opportunities illiquid investments submaster lp check out list of companies and businesses related to viking global opportunities illiquid investments submaster lp find out viking global opportunities illiquid investments submaster lp address and contact details view other people related to viking global opportunities illiquid investments submaster lp  coworkers colleagues companions etc address  railroad avenue greenwich  ct companies related to viking global opportunities illiquid investments submaster lp cikcompany namepositioncompany addressarbutus biopharma corp9 glenlyon parkway burnaby vj jaxovant sciences ltd bedford row london wcr jseditas medicine inc hurley st cambridge 9myovant sciences ltd bedford row london wcr js viking global opportunities illiquid investments submaster lp on the web persons related to viking global opportunities illiquid investments submaster lp  arbutus biopharma corpnamepositioncitymichael j abramsmanaging director burnabypaul a brennanburnabydaniel d burgessdirector san diegoherbert j conraddirector middletonbruce cousinsevp  chief financial officer burnabydexxon holdings ltdor akivajewell donaldburnabyarthur bruskin drburnabyian maclachlan drburnabymark murray drburnabymichael abrams drburnabydiane gardinerburnabyfrashier garyburnabyole andreas halvorsengreenwichrichard c henriques jrdirector whitehouse stationrichard c henriques jrburnabypatrick t higginsburnabyelizabeth howardexec vp  general counsel burnabymortimer ianburnabyhudson jamesburnabydonald gordon jewellburnabyfrank karbedirector south san franciscofrank karbeburnabydaniel l kisnersan diegodaniel l kisnerburnabymark kowalskisr vp  chief medical officer burnabyandrew lohamiltonpeter lutwychechief technology officer burnabyclarence patrick machadosan franciscokeith s manchesterdirector forrest michaelburnabymark j murraypresident  ceo burnabydan orenor akivadavid c ottgreenwichpeggy v phillipsberkeleypeggy v phillipsburnabyqvt associates gp llcnew yorkqvt fund v lpnew yorkian lennox rburnabyvivek ramaswamydirector burnabyroivant sciences ltdhamiltonrose sharon shabetgreenwichmichael j sofiachief scientific officer burnabydaniel s sundheimgreenwichwilliam t symondschief development officer burnabyvge iii portfolio ltdgreenwichviking global equities ii lpgreenwichviking global equities lpgreenwichviking global investors lpgreenwichviking global opportunities gp llcgreenwichviking global opportunities portfolio gp llcgreenwichviking global performance llcgreenwichviking long fund gp llcgreenwichviking long fund master ltdgreenwichpersons related to viking global opportunities illiquid investments submaster lp  axovant sciences ltdnamepositioncitymichael adasczikprincipal accounting officer new yorkmark altmeyerpres asg  chief comm ofc new yorkchristine mikail cvijicchief admin officer and gc seattledexxon holdings ltdor akivakathryn e falbergdirector rockvillelawrence md phd friedhoffchief development officer new yorkole andreas halvorsengreenwichdavid hungprincipal executive officer san franciscoandrew lohamiltonclarence patrick machadodirector san franciscomarion mccourtprincipal operating officer san franciscoberndt modigdirector new yorkstephen frederick mohrgeneral counsel new yorklawrence s olanoffdirector new yorkdan orenor akivailan orennew yorkdavid c ottgreenwichatul pandedirector new yorkgary p pisanodirector new yorkqvt associates gp llcnew yorkqvt fund v lpnew yorkvivek ramaswamyprincipal executive officer burnabyalan s roemernew yorkroivant sciences ltdhamiltonmarianne l romeoheadglobal trans  risk mgmt hamiltonrose sharon shabetgreenwichdaniel s sundheimgreenwichw anthony vernondirector san franciscovge iii portfolio ltdgreenwichviking global equities ii lpgreenwichviking global equities lpgreenwichviking global investors lpgreenwichviking global opportunities gp llcgreenwichviking global opportunities portfolio gp llcgreenwichviking global performance llcgreenwichviking long fund gp llcgreenwichviking long fund master ltdgreenwichgregory m weinhoffprincipal financial officer stamfordpersons related to viking global opportunities illiquid investments submaster lp  editas medicine incnamepositioncitynoubar afeyanlexingtoncharles albrightchief scientific officer cambridgeglucksmann alexandracambridgeborisy alexiscambrigehack andrewcambridgekevin bittermandirector walthambng llc owner seattlenikolic boriscambridgealexis borisydirector bostonkatrine bosleypresident and ceo cambridgegeorge churchst louisdouglas g coledirector cambridgegerald frank coxchief medical officer cambridgedeerfield healthcare innovations fund lpnew yorkmanagement co ny deerfieldmgmt hif lp deerfieldnew yorkdeerfield mgmt iii lpnew yorkdeerfield private design fund iii lpnew yorkcole douglascambridgflagship ventures fund iv general partner llccambridgeflagship ventures fund iv lp owner cambridgeflagship ventures fund ivrx lpcambridgejames e flynn owner new yorkalexandra glucksmannchief operating officer cambridgeandrew a f hackchief financial officer cambridgeole andreas halvorsengreenwichandrew hirschdirector cambridgej keith joungcambridgeedwin m kania jrcambridgebosley katrinecambridgebitterman kevincambridgemark j levincambridgedavid r liucambridgejohn mendleindirector toronto canada mjhboris nikolicdirector cambridgedavid c ottgreenwichpolaris venture management co vi llc owner walthampolaris venture partners founders fund vi lpwalthampolaris venture partners vi lpwalthamkevin p starr owner cambridgedaniel s sundheimgreenwichrobert i teppercambridgethird rock ventures gp iii lpbostonthird rock ventures iii lp owner bostontrv gp iii llcbostonakshay vaishnawdirector cambridgevge iii portfolio ltdgreenwichmyer viccambridgeviking global equities ii lpgreenwichviking global equities lpgreenwichviking global investors lp owner greenwichviking global opportunities gp llcgreenwichviking global opportunities portfolio gp llcgreenwichviking global performance llc owner greenwichviking long fund gp llcgreenwichviking long fund master ltdgreenwichfeng zhangcambridgepersons related to viking global opportunities illiquid investments submaster lp  myovant sciences ltdnamepositioncitymark altmeyerdirector new yorkterrie currandirector new yorkwayne s deveydtdirector indianapolisdexxon holdings ltdor akivaole andreas halvorsengreenwichfrank karbesouth san franciscomatthew langgeneral counsel  corp secy brisbaneandrew lohamiltonclarence patrick machadosan franciscokeith s manchesterdan orenor akivadavid c ottgreenwichqvt associates gp llcnew yorkqvt fund v lpnew yorkvivek ramaswamyburnabyroivant sciences ltdhamiltonmarianne l romeohamiltonkathleen sebeliusdirector menlo parklynn seelyprincipal executive officer san franciscorose sharon shabetgreenwichdaniel s sundheimgreenwichpharmaceuticals international ag takeda owner zurichvge iii portfolio ltdgreenwichviking global equities ii lpgreenwichviking global equities lpgreenwichviking global investors lpgreenwichviking global opportunities gp llcgreenwichviking global opportunities portfolio gp llcgreenwichviking global performance llcgreenwichviking long fund gp llcgreenwichviking long fund master ltdgreenwich initial statement of beneficial ownership  july edition of canna investorshub magazine now available support 99  newswire  home  log in boards stocks commodities forex cryptocurrency the lounge hot breakout boards ihub my stocks activity ticker buzz cloud most read most posted most followed members recent news active boards site stats new boards cannabis stocks tools data tools  charts trader alerts trades portfolio top lists price  news alerts commodities markets in d newswire more tools  newsletters my image gallery advanced search videos all news stock screener news filter live charts live news live desktop forex prices commodities etf center educational channel personal finance qa streamer level  follow feed quotechartlevel tradesnewsfinancialshistoricaltechnical analysismessage boardarbutus biopharma corp mm nasdaq initial statement of beneficial ownership  date    pm source  edgar us regulatory stock  arbutus biopharma corp mm abus quote       pm initial statement of beneficial ownership tweet print form           united states securities and exchange commission washington dc  initial statement of beneficial ownership of securities omb approval omb number  estimated average burden hours per response                         filed pursuant to section a of the securities exchange act of 9 or section h of the investment company act of 9                         name and address of reporting person  shabet rose sharon  date of event requiring statement mmddyyyy    issuer name and ticker or trading symbol arbutus biopharma corp abus last        first        middle  railroad avenue  relationship of reporting persons to issuer check all applicable  director                             x   owner  officer give title below           other specify below street greenwich ct         city              state              zip  if amendment date original filed mmddyyyy    individual or jointgroup filing check applicable line  x  form filed by one reporting person  form filed by more than one reporting person table i  nonderivative securities beneficially owned title of security instr   amount of securities beneficially owned instr   ownership form direct d or indirect i instr   nature of indirect beneficial ownership instr  common shares      i   see explanation of responses       table ii  derivative securities beneficially owned  eg  puts calls warrants options convertible securities  title of derivate security instr   date exercisable and expiration date mmddyyyy  title and amount of securities underlying derivative security instr   conversion or exercise price of derivative security  ownership form of derivative security direct d or indirect i instr   nature of indirect beneficial ownership instr  date exercisable expiration date title amount or number of shares explanation of responses   rose s shabet does not directly own any shares of common stock the common shares of arbutus biopharma corporation the issuer as of july   ms shabet became an executive committee member of viking global partners llc the general partner of viking global investors lp vgi viking global performance llc vgp viking long fund gp llc vlfgp and viking global opportunities gp llc opportunities gp the sole owner of viking global opportunities portfolio gp llc opportunities portfolio gp   vgi provides managerial services to various investment funds including viking global equities lp vge viking global equities ii lp vge ii vge iii portfolio ltd vge iii viking long fund master ltd vlfm and viking global opportunities illiquid investments submaster lp opportunities fund and together with vge vge ii vge iii and vlfm the funds and the funds together with vgi vgp vlfgp opportunities gp and opportunities portfolio gp the viking entities vgp is the general partner of vge and vge ii and the investment manager of vge iii vlfgp serves as the investment manager of vlfm opportunities gp serves as the sole member of opportunities portfolio gp opportunities portfolio gp serves as the general partner of opportunities fund the viking entities previously disclosed their beneficial ownership of the common shares on form s dated july     the viking entities acquired roivant sciences ltd roivant common shares the roivant common shares on december   roivant directly holds the  common shares reported herein as a result of certain governance arrangements set forth in roivants byelaws due to the appointment of one or more independent directors within the meaning of that term under roivants byelaws to roivants board of directors ms shabet may be deemed to have beneficial ownership over the common shares held by roivant   ms shabet disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of section  of the securities exchange act of 9 as amended the exchange act or for any other purpose reporting owners reporting owner name  address relationships director  owner officer other shabet rose sharon  railroad avenue greenwich ct  x signatures s rose s shabet   signature of reporting person date reminder report on a separate line for each class of securities beneficially owned directly or indirectly  if the form is filed by more than one reporting person see instruction bv  intentional misstatements or omissions of facts constitute federal criminal violations see  usc  and  usc ffa note file three copies of this form one of which must be manually signed if space is insufficient see instruction  for procedure persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid omb control number arbutus biopharma corporation nasdaqabushistorical stock chart  year  from jul  to jul  arbutus biopharma corporation nasdaqabusintraday stock chart today  saturday 9 july  latest abus messages view more posts remove from favorites add to favorites  students be the first to share words of wisdom youll get  in tutor credits for sharing advice on  courses give advice asu top courses fin   fundamentals of corporate finance  documents soc   introductory sociology  documents cse   java  documents ecn   macroeconomics  documents cse   homework   documents acc   tax  documents eee   circuits   documents scm   scm  documents chm   documents ecn   documents browse schools tweet ask a homework question  tutors are online